On neuromuscular blockers, safety and more

1. Viby-Mogensen J, J0rgensen BC, Ording H. Residual curarization in the recovery room. Anesthesiology. 1979;50:539-11.

2. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042-8.

3. Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105:304-9.

4. Reyes LE, Muñoz L, Orozco D, Arias C, Vergel V, Valencia A. Variabilidad clínica del vecuronio. Experiencia en una institución en Colombia. Rev Colomb Anestesiol. 2012 http://dx.doi.org/10.1016/j.rca.2012.06.003

5. Kopman AF, Lien CA, Naguib M. Neuromuscular dose-response studies: determining sample size. Br J Anaesth. 2011;106:194-8.

6. Naguib M, Kopman A, Cynthia AL, Hunter J, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111:110-9.

7. Fabregat López J, Candia Arana C, Castillo Monzón CG. La monitorizacioin neuromuscular y su importancia en el uso de los bloqueantes neuromusculares. Rev Colomb Anestesiol. 2012;40:293-303.

8. Claudius C, Karacan H, Viby-Mogensen J. Prolonged residual paralysis after a single intubating dose of rocuronium. Br J Anaesth. 2007;99:514-7.

9. Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol. 2011;28:842-8.

10. Murphy GS, Szokol JW, Marymount JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130-7.